Related Experiment Video
Updated: Jun 10, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Tuberculosis Annual Report 2008--Series 9. Treatment of TB (2)]
Abstract:
The standard treatment for tuberculosis (TB) is the key to its control. Here we report on the statistics of treatment status and the duration of hospitalization/treatment. The place of initial treatment was observed among newly notified TB patients (n = 24,760) in 2008. Of those, the proportion receiving treatment in hospital among sputum smear positive pulmonary TB patients was the most (91.7%), including 2.1% hospitalized mainly due to other diseases. The proportion receiving treatment in hospital among bacteriologically negative pulmonary TB cases was the least (25.8%), including 10.3% hospitalized mainly due to other diseases. This proportion of patients receiving treatment in hospital did not differ with age, among sputum smear positive pulmonary TB cases. But, this proportion differed greatly in their age groups (e.g. 9.9% in their 20s, 25.7% in their 50s and 50.0% in their 80s), among bacteriologically negative pulmonary TB cases. The duration of hospitalization for TB treatment among newly notified cases in 2007 was observed at the end of 2008. The median hospitalization periods were 69 days, 74 days, 45 days, 38 days and 45 days, among new sputum smear positive pulmonary TB cases, retreatment sputum smear positive pulmonary TB cases, other bacillary positive pulmonary TB cases, bacilli negative pulmonary TB cases and extra-pulmonary TB cases, respectively. The duration of TB treatment among newly notified cases in 2007 was observed at the end of 2008. The median treatment duration among all forms of TB was 273 days. The longest median treatment duration was 298 days for retreatment sputum smear positive pulmonary TB cases and the shortest was 204 days for bacteriologically negative pulmonary TB cases.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis
